Cell identity signals influence the invasive capability of tumor cells, as demonstrated by the selection for programs of epithelialto-mesenchymal transition (EMT) during malignant progression. Breast cancer cells retain canonical epithelial traits and invade collectively as cohesive groups of cells, but the signaling pathways critical to their invasive capabilities are still incompletely understood. Here we report that the transcription factor DNp63a drives the migration of basal-like breast cancer (BLBC) cells by inducing a hybrid mesenchymal/epithelial state. Through a combination of expression analysis and functional testing across multiple BLBC cell populations, we determined that DNp63a induces migration by elevating the expression of the EMT program components Slug and Axl. Interestingly, DNp63a also increased the expression of miR-205, which can silence ZEB1/2 to prevent the loss of epithelial character caused by EMT induction. In clinical specimens, co-expression of various elements of the DNp63a pathway confirmed its implication in motility signaling in BLBC. We observed that activation of the DNp63a pathway occurred during the transition from noninvasive ductal carcinoma in situ to invasive breast cancer. Notably, in an orthotopic tumor model, Slug expression was sufficient to induce collective invasion of E-cadherin-expressing BLBC cells. Together, our results illustrate how DNp63a can drive breast cancer cell invasion by selectively engaging promigratory components of the EMT program while, in parallel, still promoting the retention of epithelial character.
Introduction
The invasive phenotypes of tumor cells are dependent on signaling pathways that control cell identity (1) . For example, extracellular stimuli can alter cell state by promoting an epithelialto-mesenchymal transition (EMT; ref. 2) . The EMT program involves the silencing of epithelial traits, such as the expression of cell-cell adhesion proteins, and the induction of mesenchymal traits, including promigratory cytoskeletal proteins and proteases (3) . Cells that complete the EMT process acquire a mesenchymallike phenotype and can invade as single cells. However, while a full EMT can promote aggressive single-cell invasion, tumor cells may also invade while retaining epithelial traits (4) . For instance, at least 50% of invasive breast tumors have epithelial characteristics, including the expression of E-cadherin (5, 6), claudinfamily tight junctions proteins (7) , and EpCAM (8) . Instead of invading as single cells, epithelial-like breast cancer cells frequently engage in a process called collective invasion (9, 10) , in which tumor cells invade as cohesive groups through paths in the extracellular matrix (ECM; ref. 11) . There is heterogeneity with respect to the autonomous invasive traits of epithelial-like breast cancer populations derived from different patient tumors (9, 10) . Notably, basal-like breast cancer (BLBC) cells are intrinsically motile and can collectively invade into paths generated by fibroblasts while maintaining epithelial features, including the expression of E-cadherin (9) . By comparison, luminal-type breast cancer (LBC) cells are an epithelial-like cell type with relatively weak intrinsic migratory and invasive ability (9) . Importantly, BLBC cells are distinguished from LBC cells by patterns of gene expression (7, 12) , indicating that these populations represent two distinct epithelial-like cell identities and that the BLBC identity can be an epithelial-like cell state that has an enhanced invasive behavior. Thus, we sought to determine the nature of the cell signaling networks that can confer BLBC cells with an invasive phenotype.
BLBC is diagnosed in approximately 15% of patients, with most BLBC tumors being classified as triple-negative breast cancer [TNBC; no detectable estrogen receptor (ER), progesterone receptor (PR) or HER2 expression; ref . 13] . The motility and invasion of BLBC cells can require EGFR and ERK1/2 kinase activity (9) ; however, the mechanistic basis of the requirement of these kinases is unknown. Interestingly, BLBC cells can be a hybrid cell type that maintains canonical epithelial traits, such as E-cadherin expression, while also expressing a subset of mesenchymal genes, including transcription factors and cytoskeletal proteins that are increased in expression during the induction of EMTs (14) (15) (16) .
While tumor cells in a hybrid state can have enhanced invasive traits (17) , whether elements of hybrid states functionally contribute to invasive phenotypes is not known. It is also unclear how a hybrid state is induced in BLBC cells. Thus, the cell signaling pathways that confer BLBC cells with invasive traits are poorly understood.
microRNAs (miRNA) regulate cell identity by inducing the posttranscriptional silencing of genes through mRNA destabilization and antagonizing translation. Therefore, to define signaling pathways essential for BLBC migration, we determined the wound closure rate of a model BLBC cell line transfected with 879 miRNAs. Functional requirements for migration in wound-healing assays can reflect necessary traits for invasion and metastasis in mouse models of breast cancer (18, 19) ; thus, this approach had the potential to reveal key elements of BLBC invasion in vivo. By combining the results of our wounding screen with miRNA expression profiling, we found that miR-203a was highly expressed in LBC cells and can suppress BLBC motility by silencing the transcription factor DNp63a. Interestingly, DNp63a enhances the expression of miR-205, which increases BLBC migration rate and can block cells from converting to a mesenchymal state by silencing ZEB1 and ZEB2. Further investigation revealed that DNp63a promoted motility by inducing the transcription factor Slug (SNAI2) and the tyrosine kinase Axl, both of which can contribute to the EMT programs. Thus, DNp63a confers BLBC cells with a migratory phenotype through inducing a hybrid state in which components of EMT programs promote migration, whereas the parallel activation of a miRNA maintains key features of epithelial character.
Materials and Methods
See Supplementary Methods for additional details.
Cell culture and reagents
MCFDCIS cells were purchased from Asterand. T47D and MCF7 cells were purchased from ATCC. HCC1428, HCC1806, and HCC1954 cells were a gift from John Minna (University of Texas Southwestern Medical Center, Dallas, TX). All cell lines were validated by Powerplex genotyping before use. All cells were cultured at 5% CO 2 and humidified at 37 C. MCFDCIS cells were cultured in DMEM/F12, 5% horse serum, 20 ng/mL EGF, 0.5 mg/mL hydrocortisone, 100 ng/mL cholera toxin, 10 mg/mL insulin, and 1Â penicillin/streptomycin. SUM149 cells were cultured in mammary epithelial growth medium (MEGM, Lonza). All other cell lines were cultured in 10% FBS, RPMI.
Wounding assay
Seventy-two hours after transfection, confluent cells in glassbottom 96-well plates (BD Biosciences) were wounded with a 96-pin wounding tool (AFIX96FP6, V&P Scientific) containing 1.68-mm-diameter pins (FP6-WP) and a monolayer wounding library copier that introduces a wound length of 4.5 mm (VP 381NW 4.5, V&P Scientific). Immediately after wounding, wells were washed twice with media to remove debris. Twenty-four hours after wounding, cells were fixed in 2% formaldehyde and stained with phalloidin-546 and Hoechst. Wounds were imaged on a BD Pathway 855 microscope with a 10Â objective (Olympus, UPlanSApo 10Â/0.40, ¥/0.17/FN26.5). Images were acquired as 4 Â 5 or 6 Â 4 montages. An automated image analysis protocol that used a threshold of pixel intensity to define cell-free space was used to quantify wound closure.
Time-lapse imaging
Imaging was performed using a Perkin Elmer Ultraview ERS spinning disk confocal microscope enclosed in a 37 C chamber supplemented with humidified CO 2 (Solent) and a CCD camera (Orca AG; Hamamatsu). Images were acquired for at least 5 xy points per condition for 7 hours at 30-minute intervals in each experiment with a 10Â (Zeiss) objective using Volocity software (Perkin Elmer). Cell displacement and speed were determined with Imaris software (Bitplane) as described (9) .
Transfection of siRNAs and miRNAs
Cells were transfected with 5 to 50 nmol/L of siRNA or 10 to 50 nmol/L of miRNA mimic using RNAiMax (Invitrogen). Control cells in siRNA-based experiments were transfected with a pool of siRNAs that does not target human genes. Control cells in miRNA-based experiments were transfected with miR-545, which produced no phenotype compared with mock-transfected cells (no siRNA) or control siRNA-transfected cells ( Supplementary  Fig. S1A ).
Quantitative real-time PCR
Quantitative real-time PCR was performed as described (20) .
Immunoblotting, immunofluorescence, and live imaging All experiments were performed as described (9) . Immunoblotting was performed on lysates from cells transfected with siRNAs or miRNAs for 72 hours.
Xenografts
All experiments were approved by the Institutional Animal Care and Use Committee and performed in compliance with the relevant laws and institutional guidelines of the University of Texas Southwestern Medical Center. Age-matched female NOD/ SCID mice were used for all in vivo experiments. When possible, littermates were housed together. NOD/SCID mice were obtained from The Jackson Laboratory and bred and maintained under specific pathogen-free conditions in a barrier facility at the University of Texas Southwestern Medical Center. Fifty thousand each of MCFDCIS cells and MCFDCIS cells combined with 200,000 mammary fibroblasts or 50,000 MCFDCIS-Slug cells were injected in the fourth mammary fat pad of 6-to 8-week-old NOD/SCID female mice as described (9) . Three weeks after injection, mice were sacrificed and the tumors were removed for embedding in paraffin.
Gene and miRNA expression profiling
The mRNA expression was determined using Human HT-12 v4 Expression BeadChips (Illumina Inc.). miRNA expression was determined using Exiqon 7th generation arrays (#208502). Heatmaps showing the relative expression of genes were generated with GenePattern software using the HeatMapImage module (21) . The mRNA and miRNA expression data are available at the GEO (GSE58643, GSE62569).
Breast cancer patient survival analysis
The correlation between p63 expression and breast cancer patient survival time was performed using the Kaplan-Meier plotter meta-analysis database (22) . ER À
/HER2
À (basal-type) and ER þ /HER2 À (luminal A) patients were stratified into "p63-low"
and "p63-high" groups on the basis of the lower tertile of p63 expression (Gene ID 209863).
Statistical analysis
For the miRNA wounding screen, wounding activities were normalized to internal controls and z-scores were calculated [z-score ¼ (miRNA activity score À mean activity score of mock-transfected cells)/(SD of mock-transfected cells)]. Fluorescence values were normalized to internal controls. For mRNA and miRNA expression analysis, data were processed with a modelbased background correction approach (23), quantile-quantile normalization, and log 2 transformation. Wound-healing and spontaneous motility assays were analyzed by unpaired Student t tests (2-tailed) using Prism software (GraphPad). Patient survival differences were compared by log-rank (Mantel-Cox) test using Prism software (GraphPad).
Results

Identification of miRNAs that regulate basal-type breast cancer cell migration
To define signaling pathways required for BLBC migration, we determined the wound closure rate of MCFDCIS cells transfected with 879 miRNA mimics in a one-condition/one-well format (Fig. 1A) . MCFDCIS cells are a BLBC population (24) that completes wound closure within 24 hours, which reduces the contribution of proliferation to observed phenotypes. Importantly, MCFDCIS cells invade in organotypic culture and in vivo while maintaining epithelial character (9, 24, 25) . Cells were cultured for 72 hours after reverse transfection, which allowed miRNAs to directly silence target genes and induce indirect changes in gene expression and signaling pathway characteristics. Equivalent wounds were introduced using a 96-pin wounding tool (Fig.  1A ) and allowed to close for 24 hours, after which cells were fixed, imaged, and analyzed (Fig. 1A, Supplementary Fig. S1B and Supplementary Table S1 ). The total fluorescence of the wounded cells served as an indicator of the relative cell number for each condition ( Supplementary Fig. S1B and Supplementary Table S1 ). Because significant reductions in cell number can reduce the extent of wound closure (18, 26) , we focused on the 574 miRNAs that induced a 50% reduction in fluorescent signaling intensity (Fig. 1B, Supplementary Fig. S1C and Supplementary Table S2 ). Retesting of 132 miRNA mimics showed a correlation in wounding response ( Supplementary Fig. S1D and Supplementary Table S3) , and miRNA mimics with identical seed sequences (positions 2-7) had similar phenotypes ( Supplementary Fig. S1E ).
To further prioritize analysis, we determined which miRNAs that inhibited wound closure may maintain LBC cells in a nonmotile state. Of the 41 miRNAs expressed !2-fold higher in HCC1428 LBC cells (9) than in MCFDCIS cells, miR-203a most potently suppressed wound closure with a nominal inhibition of cell growth (Fig. 1C and Supplementary Tables S4 and S5 ). miR203a was also more highly expressed in nonmotile MCF7 and T47D LBC cells (9), compared with motile HCC1806 and HCC1954 BLBC cells ( Fig. 1D and Supplementary Fig. S2A; ref. 9 ). These results indicate that miR-203a may maintain a nonmotile state in LBC cells by silencing signaling pathways that confer BLBC cells with a migratory ability.
Interestingly, our analysis also revealed that miR-205 was the only miRNA expressed !2-fold higher in MCFDCIS cells that enhanced wound closure rate. MiR-205 also increased the spontaneous motility of SUM149 BLBC cells ( Supplementary Fig. S2B ), further indicating that miR-205 can endogenously function to promote BLBC motility. In addition, miR-203a transfection reduced miR-205 expression (Fig. 1E) , suggesting that miR-205 is a component of a signaling pathway that promoted the motile phenotype of BLBC cells and could be suppressed by miR-203a (Fig. 1F ).
DNp63a regulates cell migration
To define how miR-203a controlled miR-205 expression, we determined which predicted targets of miR-203a were co-expressed with miR-205 in breast cancer patient tumors (Supplementary Fig. S2C-S2E and Supplementary Table S6 ). The transcription factor p63 was one of 4 predicted miR-203a target genes that were co-expressed with miR-205 ( Fig. 2A) . p63 is necessary for miR-205 expression in bladder cancer cells and miR-203a can suppress p63 expression in normal mammary epithelial cells (27, 28) , suggesting that miR-203a may regulate miR-205 levels by silencing p63. Of the six p63 isoforms (29) , DNp63a was the dominant isoform expressed in the MCFDCIS cells (Supplementary Fig. S2F ). DNp63a was also silenced by miR203a (Fig. 2B and C) and DNp63a was necessary for miR-205 expression (Fig. 2D) .
The requirement of DNp63a for miR-205 expression suggested that DNp63a may promote BLBC motility. Indeed, p63 siRNAs reduced MCFDCIS and HCC1806 motility (Fig. 2E and F and Supplementary Fig. S3A-S3C) , with the targeting specificity of the individual p63 siRNAs indicating that migration specifically required DNp63a (Supplementary Fig. S3D ). Exogenous miR-205 was not sufficient to promote wound closure in DNp63a-depleted MCFDCIS cells (Fig. 2G) , indicating that additional DNp63a regulated signaling components were required for motility. Together, these results suggest that DNp63a promotes the motile phenotype of BLBC cells through the induction of miR-205 (Fig. 2H) . In addition, miR-203a may sustain LBC identity by antagonizing the expression of a DNp63a-dependent signaling network (Fig. 2H) .
DNp63a regulates parallel signaling pathways that are required for collective migration
To define the additional DNp63a-regulated events required for migration, we determined that 181 genes were dependent on DNp63a for expression (!2-fold reduction, P < 0.05) in both MCFDCIS and HCC1806 cells ( Supplementary Fig. S4A and Supplementary Table S7 ). Sixty-one of these DNp63a-regulated genes were expressed at a higher level in motile MCFDCIS and HCC1806 BLBC cells compared with nonmotile HCC1428 and MCF7 LBC cells (!2-fold, P < 0.05), suggesting that they may confer BLBC cells with migratory ability (Supplementary Fig. S4A and Supplementary Tables S7-S9) . To further prioritize analysis, we determined that 11 of the DNp63a regulated "motility" genes were coexpressed with DNp63a in breast cancer patient tumors, indicating that they may contribute to DNp63a-dependent cell behaviors in vivo ( Supplementary Fig. S4A and S4B and Supplementary Table S10 ). One of these DNp63a-regulated genes was the transcription factor Slug (SNAI2; Fig. 3A) , which can promote EMT and invasion (30) by binding to an E-Box site in the E-cadherin promoter to silence E-cadherin expression (31) . However, because BLBC cells can express E-cadherin, it was not clear C, wound healing of MCFDCIS cells transfected as indicated. Scale bars, 1 mm. Graph shows relative wound area (mean þ SD; n ¼ 6 wounds from two independent experiments). ÃÃÃÃ , P < 0.0001, unpaired Student t test. D, MCFDCIS cells transfected as indicated were wounded and imaged for 7 hours. Scale bars, 100 mm. Graphs show cell speed and displacement (mean AE SD; n ¼ 10 x, y positions over two independent experiments). ÃÃÃÃ , P < 0.0001, unpaired Student t test. E, wound healing of MCFDCIS and MCFDCIS-Slug cells transfected as indicated. Scale bars, 1 mm. Graph shows quantification of wound area (mean þ SD, n ¼ 9 wounds from three independent experiments). ÃÃÃÃ , P < 0.0001, unpaired Student t test. F, model showing DNp63a regulation of Slug and miR-205.
whether Slug expression was innocuous in BLBC cells or whether Slug contributed to migration through a different mechanism. Therefore, to determine whether factors that contribute to EMT could promote the motile phenotype of hybrid mesenchymal/ epithelial BLBC cells, we further investigated the regulation of Slug by DNp63a.
Consistent with our gene expression analysis, DNp63a was necessary for Slug protein expression in MCFDCIS, HCC1806, and HCC1954 cells (Fig. 3B and Supplementary Fig. S5A ). Importantly, Slug was required for MCFDCIS and HCC1806 motility (Fig. 3C and D and Supplementary Fig. S5B-S5D) , and Slug overexpression increased the rate of MCFDCIS wound closure (Fig. 3E) . However, MCFDCIS-Slug cells remained dependent on DNp63a for migration (Fig. 3E) , demonstrating that Slug was one of the multiple genes regulated by DNp63a that were necessary for BLBC motility (Fig. 3F) .
Our discovery that DNp63a could regulate Slug expression suggested that DNp63a may promote motility through the regulation of additional genes that can contribute to EMTs. The EMT-related tyrosine kinase Axl (32) was one of the 61 "motility" genes dependent on DNp63a for expression. In addition, a potential DNp63a interaction site was detected within the Axl promoter ( Fig. 4A and Supplementary Fig. S6A ) on the basis of ChIP-seq experiments performed in keratinocytes (33, 34) . Indeed, DNp63a could bind to the Axl promoter in MCFDCIS cells (Fig. 4A) , and DNp63a was necessary for Axl protein Fig. 4B and Supplementary Fig. S6B ). Slug depletion also partially reduced Axl levels and exogenous Slug partially sustained Axl expression in the absence of DNp63a (Fig. 4B) , indicating that in addition to directly binding to the Axl promoter, DNp63a may control Axl expression through the induction of Slug. Interestingly, DNp63a and Slug were partially dependent on Axl for expression (Fig. 4B) , suggesting that Axl functions within a positive feedback loop that contributes to DNp63a and Slug regulation. Axl siRNAs and a pharmacologic inhibitor of Axl, R428 (35) , reduced MCFDCIS wound closure, demonstrating that DNp63a-induced Axl expression contributed to BLBC motility ( Fig. 4C and Supplementary Fig. S6C ). However, exogenous Axl did not rescue the migration defects of DNp63a-depleted MCFDCIS cells (Fig. 4C) , indicating that Slug and Axl each have distinct functions that promote BLBC motility.
Although Slug or Axl overexpression can induce a complete EMT and conversion to a mesenchymal state (36, 37) , their combined expression did not trigger the BLBC cells to shed their epithelial traits (Fig. 4D) . DNp63a can promote the retention of epithelial character through inducing miR-205, which can silence ZEB1 and ZEB2 to prevent a conversion to a mesenchymal state (38, 39) . As has been previously observed (38, 40) , transfection of mesenchymal-like breast cancer cells (MBC) with miR-205 suppressed ZEB1 and ZEB2 expression ( Supplementary Fig. S6D ) and reduced cell motility (Supplementary Fig. S6E ). Similar to observations in prostate and bladder cancer (27, 39) , DNp63a and miR-205 were also expressed at a low level in MBC (Fig. 4D) . These results suggest that high levels of DNp63a and miR-205 contribute to the retention of epithelial character in BLBC cells and that low levels of DNp63a and miR-205 are necessary for breast cancer cells to adopt a mesenchymal state. Interestingly, Axl and Slug were expressed at a high level in the mesenchymal-like cells (Fig.  4D) . Given the low DNp63a expression in these cells, Slug and Axl may be induced by p63-independent pathways in mesenchymaltype cells, which suggests that the mechanism of Slug and Axl activation may influence cell identity. Together these results suggest that DNp63a can increase Slug and Axl expression to promote motility, while simultaneously inducing miR-205, which can silence signaling pathways that suppress epithelial traits (Fig. 4E) .
DNp63a is not sufficient to induce motility, Slug, or Axl expression in LBC cells
We next determined whether DNp63a was sufficient to confer intrinsically nonmotile HCC1428 LBC cells with a migratory phenotype. Exogenous DNp63a increased miR-205 expression (Fig. 5A ), indicating that DNp63a was capable of interacting with DNA and promoting transcription in LBC cells. However, DNp63a overexpression did not increase Slug and Axl protein levels (Fig. 5B) or accelerate the rate of HCC1428 cell wound closure (Fig. 5C ). miR-203a can directly silence Slug expression (41) , and on the basis of the Targetscan algorithm (42), miR-203a is predicted to target the 3 0 -untranslated region (UTR) of Axl (Supplementary Fig. S6F ). This suggested that the high level of endogenous miR-203a in HCC1428 cells may prevent DNp63a from inducing Slug and Axl expression, thereby impinging on the ability of DNp63a to induce a motile state. To test this possibility, we measured the expression of Slug and Axl in MCFDCIS cells expressing exogenous DNp63a (Fig. 5D ) after transfection with miR203a. Whereas the exogenous DNp63a was resistant to depletion by miR-203, both Slug and Axl expression were silenced (Fig. 5E) . Therefore, miR-203a can silence Slug and Axl, even when there is a high-level DNp63a expression. Together, these results indicate that the low expression of miR-203a in BLBC cells permits DNp63a to induce Slug and Axl expression. Thus, the miRNA content of a cell may influence the expression of DNp63a target genes and the nature of DNp63a-induced cell phenotypes (Fig. 5F ).
DNp63a and Slug promote collective invasion in vivo
We next investigated how DNp63a expression correlated with breast cancer patient survival time. Interestingly, high DNp63a expression correlated with shorter overall survival time in ER À / HER2
À patients (Fig. 6A) ; however, no correlation between DNp63a expression and ER þ /HER2 À patient survival was observed (Fig. 6A) . These clinical observations are consistent with our results showing that DNp63a can contribute to the motile state of ER À /HER2 À breast cancer cells, which frequently are classified as BLBC tumors (13) .
To determine how DNp63a signaling contributes to cell phenotypes in primary tumors, we examined DNp63a and Slug expression in MCFDCIS orthotopic xenografts. MCFDCIS cells are a unique cell type that forms noninvasive ductal carcinoma in situ (DCIS) lesions (24, 25) . DNp63a and Slug were expressed in the smooth muscle actin (SMA)-positive myoepithelial cell layer that forms around the xenograft DCIS lesions (Fig. 6B) . However, DNp63a and Slug were rarely detected in the central luminal epithelial populations (Fig. 6B) . DNp63a was expressed in all cells in monolayer culture (Supplementary Fig. S7A ) and is positively regulated by cell attachment (24) and contact with ECM (10), which suggests that DNp63a levels are reduced in the luminal MCFDCIS cells due to a lack of cell-ECM contact (24) . Consistent with this possibility, myoepithelial cells, basal mammary epithelial cells, and mammary stem cells, all interact with ECM components and express DNp63a, Slug, and miR-205 (43) (44) (45) (46) (47) (48) . Interestingly, DNp63a and Slug expression were high in SMA-negative MCFDCIS cells induced to invade by fibroblasts (Fig. 6B) , suggesting that the induction of DNp63a and Slug was contributing to the transition from DCIS to invasive breast cancer. However, we were unable to stably reduce DNp63a and Slug expression with shRNAs to determine whether either gene was required for MCFDCIS invasion. This may be because both DNp63a and Slug were both necessary for long-term cell growth ( Supplementary  Fig. S7B ). Nevertheless, our results showed that the DNp63a pathway was activated during the initiation of invasion.
We next determined whether the DNp63a pathway was sufficient to induce invasion. While we were able to exogenously express DNp63a in MCFDCIS cells in monolayer culture (Supplementary Fig. S2E ), the overexpressed DNp63a was not detected in the xenografts tumors, consistent with previous observations (24) . This suggests that DNp63a levels are controlled by a posttranscriptional regulatory mechanism (24) or that a precise level of DNp63a expression is needed for tumor formation. Because DNp63a was potentially promoting invasion by increasing Slug expression, we determined whether Slug could induce invasion. Indeed, exogenous Slug was sufficient to induce the collective invasion of MCFDCIS into the ECM (Fig. 6C and Supplementary  Fig. S7C ), demonstrating that the activation of a component of the DNp63a-regulated signaling network was sufficient to promote invasion in vivo. Importantly, invasive MCFDCIS-Slug cells expressed E-cadherin, indicating that cells retained their epithelial character (Fig. 6C) . Like we observed during fibroblast-induced invasion, DNp63a expression was increased in the invasive MCFDCIS-Slug cells (Fig. 6C) , consistent with DNp63a being essential for Slug-induced motility and invasion. It is possible that DNp63a expression is increased when the MCFDCIS cells come in contact with the ECM or that Slug contributes to the induction of DNp63a expression in vivo. Together, these results demonstrate that increased Slug expression is sufficient to promote the collective invasion of DCIS cells.
Discussion
In defining how miR-203a maintained a nonmotile luminaltype state, we uncovered a DNp63a-regulated signaling network that conferred BLBC breast cancer cells with a motile phenotype. DNp63a promoted migration by inducing the expression of Slug and Axl, 2 genes that can facilitate EMT. Interestingly, DNp63a also directly increased the expression miR-205, which can enhance the rate of BLBC motility and defend against the loss of epithelial traits. Thus, DNp63a promoted motility through the induction of a hybrid mesenchymal/epithelial state. Hybrid states can be induced by sub-threshold levels of TGFb, suggesting that some hybrid states may be the result of a partial completion of an EMT program (49) . By comparison, DNp63a, Slug, and miR-205 are all expressed in mammary stem cells and myoepithelial cells (43) (44) (45) (46) (47) (48) , which raises the possibility that this DNp63a-induced hybrid state may be a pre-existing biologic program that has evolved to allow EMT-inducing genes, like Slug and Axl, to contribute to cell behavior within an epithelial lineage. Therefore, hybrid states may be conferred by signaling pathways that define normal cell identity and are not necessarily unstable transition states (3) on a path toward a conversion to a fully mesenchymal phenotype. Our results suggest that fibroblasts can promote collective invasion of BLBC cells by inducing DNp63a expression in DCIS tumors (Fig. 6D) . The tumor-associated fibroblasts may trigger DNp63a expression through paracrine communication or by physically disrupting the myoepithelial cell layer, which could result in the DCIS tumor cells gaining direct contact with activating factors located within the stromal ECM. The ability of Slug to induce MCFDCIS invasion suggests that once activated, DNp63a-dependent signaling confers BLBC cells with a motile phenotype. Interestingly, because a mesenchymal phenotype can be incompatible with growth in distant tissues (50, 51) , the ability of DNp63a to confer migratory ability through the induction of a hybrid mesenchymal/epithelial state may promote the development of metastasis more potently than signaling mechanisms that induce a complete and sustained EMT. Consistent with this possibility, circulating tumor cells (52) and metastases (3) frequently display canonical epithelial traits. Together, these findings support the investigation of DNp63a regulatory programs that may be reawakened during neoplastic progression and contribute to tumor cell invasion.
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